{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:42:05Z","timestamp":1793727725299,"version":"4.6.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Patients with ankylosing spondylitis (AS) warrant a comprehensive clinical assessment because of the lack of biomarkers of disease activity, prognosis and response to biologic therapy. Multiple AS-related questionnaires have been developed to assess the disease status accurately, but feasibility remains a problem in clinical practice. The purpose of this review is to assess the pearls and pitfalls of AS-related outcome measures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Single-item questionnaires to measure pain, stiffness and fatigue in patients with AS are easily administrable but may lack a sufficient degree of responsiveness on an individual patient level. The Bath Ankylosing Disease Activity Index remains the gold standard for assessing disease activity in a routine practice, despite poor correlation with C-reactive protein (CRP) levels and MRI inflammation. The Ankylosing Spondylitis Disease Activity Score, a validated and highly discriminatory tool for assessing disease activity in AS, has been developed but lacks feasibility as erythrocytic sedimentation rate and CRP values are often not available during a clinic visit. RAPID-3 appears feasible to assess patients with AS quantitatively over time in busy clinical settings.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>The assessment of disease status in AS is complex and is impacted by multiple factors. The biggest challenge in AS is to incorporate the disease-specific indices into a routine practice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Video abstract<\/jats:title>\n            <jats:p>\n                                 http:\/\/links.lww.com\/COR\/A42.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000588","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T21:36:51Z","timestamp":1548279411000},"page":"109-117","source":"Crossref","is-referenced-by-count":12,"title":["Measuring outcomes in ankylosing spondylitis: pearls and pitfalls"],"prefix":"10.1097","volume":"31","author":[{"given":"Marina","family":"Magrey","sequence":"first","affiliation":[{"name":"Case Western Reserve University School of Medicine, Metrohealth Medical Center, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ritchlin","sequence":"additional","affiliation":[{"name":"Allergy, Immunology Division, Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1056\/NEJMra1406182","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"374","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"issue":"(Suppl 11)","key":"R2-20230829","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1002\/acr.20575","article-title":"Measures of symptoms and disease status in ankylosing spondylitis: Ankylosing Spondylitis Disease Activity Score (ASDAS), Ankylosing Spondylitis Quality of Life Scale (ASQoL), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Global Score (BAS-G), Bath Ankylosing Spondylitis Metrology Index (BASMI), Dougados Functional Index (DFI), and Health Assessment Questionnaire for the Spondylarthropathies (HAQ-S)","volume":"63","author":"Zochling","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.rdc.2016.01.011","article-title":"Patient-reported outcomes in axial spondyloarthritis","volume":"42","author":"Nhan","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/art.10397","article-title":"Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires","volume":"47","author":"Van Tubergen","year":"2002","journal-title":"Arthritis Rheum"},{"key":"R5-20230829","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13643-018-0777-7","article-title":"Quality and acceptability of patient-reported outcome measures used to assess fatigue in axial spondyloarthritis (axSpA): a systematic review (protocol)","volume":"7","author":"Pearson","year":"2018","journal-title":"Syst Rev"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1136\/annrheumdis-2015-208251","article-title":"Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort","volume":"75","author":"Desthieux","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7525-9-36","article-title":"Psychometric characteristics of the short form 36 health survey and functional assessment of chronic illness therapy-fatigue subscale for patients with ankylosing spondylitis","volume":"9","author":"Revicki","year":"2011","journal-title":"Health Qual Life Outcomes"},{"key":"R8-20230829","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/annrheumdis-2012-201999","article-title":"MRI inflammation and its relation with measures of clinical disease activity and different treatment responses in patients with ankylosing spondylitis treated with a tumour necrosis factor inhibitor","volume":"71","author":"Machedo","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/annrheumdis-2011-200508","article-title":"The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study","volume":"71","author":"Kiltz","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3899\/jrheum.151244","article-title":"The minimum clinically important improvement and patient-acceptable symptom state in the BASDAI and BASFI for patients with ankylosing spondylitis","volume":"43","author":"Kviatkovsky","year":"2016","journal-title":"J Rheumatol"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/rheumatology\/kew303","article-title":"Fluctuations in patient reported disease activity, pain and global being in patients with ankylosing spondylitis","volume":"55","author":"Essers","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11926-015-0522-3","article-title":"Clinical tools to assess and monitor spondyloarthritis","volume":"17","author":"Landew\u00e9","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2009.111187","article-title":"Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors","volume":"69","author":"Pedersen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.38921","article-title":"Calculating the ankylosing spondylitis disease activity score if the conventional c-reactive protein level is below the limit of detection or if high-sensitivity c-reactive protein is used: an analysis in the DESIR cohort","volume":"67","author":"Machado","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"e000283","DOI":"10.1136\/rmdopen-2016-000283","article-title":"Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: data from the SPACE cohort","volume":"2","author":"Rubio Vargas","year":"2016","journal-title":"RMD Open"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cutoff values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1136\/annrheumdis-2018-213184","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states","volume":"77","author":"Machado","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1136\/annrheumdis-2017-212178","article-title":"An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS","volume":"77","author":"Molto","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1756-185X.2010.01537.x","article-title":"Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis","volume":"13","author":"Nas","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"R22-20230829","first-page":"752","article-title":"Active disease requiring TNF-alpha antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis","volume":"28","author":"Aydin","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1136\/ard.2009.124206","article-title":"Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis","volume":"69","author":"Machado","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/ard.2008.091793","article-title":"Physical function in ankylosing spondylitis is independently determined by both disease activity and radiographic damage of the spine","volume":"68","author":"Landew\u00e9","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R25-20230829","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"R26-20230829","first-page":"302","article-title":"Evaluation of a functional index and an articular index in ankylosing spondylitis","volume":"15","author":"Dougados","year":"1988","journal-title":"J Rheumatol"},{"key":"R27-20230829","first-page":"946","article-title":"A modification of the Health Assessment Questionnaire for the spondyloarthropathies","volume":"17","author":"Daltroy","year":"1990","journal-title":"J Rheumatol"},{"issue":"(Suppl)","key":"R28-20230829","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1002\/art.11412","article-title":"Ankylosing spondylitis measures","volume":"49","author":"Moncur","year":"2003","journal-title":"Arthritis Care Res"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1136\/ard.2004.027185","article-title":"ICF based comparison of disease specific instruments measuring physical functional ability in ankylosing spondylitis","volume":"64","author":"Sigl","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R30-20230829","first-page":"1694","article-title":"Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index","volume":"21","author":"Jenkinson","year":"1994","journal-title":"J Rheumatol"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/ard.2007.074724","article-title":"Proposal of a linear definition of the Bath Ankylosing Spondylitis Metrology Index (BASMI) and comparison with the 2-step and 10-step definitions","volume":"67","author":"van der Heijde","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/ard.2004.029728","article-title":"Association between radiographic damage of the spine and spinal mobility for individual patients with ankylosing spondylitis: can assessment of spinal mobility be a proxy for radiographic evaluation?","volume":"64","author":"Wanders","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/ard.2008.104117","article-title":"ASAS\/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health","volume":"69","author":"Boonen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/annrheumdis-2018-213464","article-title":"Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study","volume":"77","author":"Rodrigues Manica","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/ard.62.1.20","article-title":"Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis","volume":"62","author":"Doward","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-7525-5-7","article-title":"Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire","volume":"5","author":"Doward","year":"2007","journal-title":"Health Qual Life Outcomes"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/rheumatology\/41.11.1295","article-title":"Disease specific, patient-assessed measures of health outcome in ankylosing spondylitis: reliability, validity and responsiveness","volume":"41","author":"Haywood","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"R38-20230829","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/annrheumdis-2013-203967","article-title":"Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS","volume":"74","author":"Kiltz","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2017-212076","article-title":"Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis","volume":"77","author":"Kiltz","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"e000311","DOI":"10.1136\/rmdopen-2016-000311","article-title":"Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages","volume":"2","author":"Kiltz","year":"2016","journal-title":"RMD Open"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","article-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis","volume":"44","author":"Anderson","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R42-20230829","first-page":"1751","article-title":"Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept","volume":"32","author":"Davis","year":"2005","journal-title":"J Rheumatol"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","article-title":"Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis","volume":"63","author":"Brandt","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1136\/ard.2011.150037","article-title":"A stratified model for health outcomes in ankylosing spondylitis","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R45-20230829","first-page":"851","article-title":"Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER network","volume":"33","author":"Che","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/rheumatology\/kep333","article-title":"An open-source, self-explanatory touch screen in routine care. Validity of filling in the Bath measures on Ankylosing Spondylitis Disease Activity Index, Function Index, theHealth Assessment Questionnaire and Visual Analogue Scales in comparison with paper versions","volume":"49","author":"Schefte","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"R47-20230829","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"e000235","DOI":"10.1136\/rmdopen-2015-000235","article-title":"Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis","volume":"2","author":"Castrej\u00f3n","year":"2016","journal-title":"RMD Open"},{"issue":"(Suppl 39)","key":"R49-20230829","first-page":"S19","article-title":"Development of a multidimensional health assessment questionnaire (MDHAQ) for the infrastructure of standard clinical care","volume":"23","author":"Pincus","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"R50-20230829","first-page":"211","article-title":"RAPID3: an index of physical function, pain, and global status as \u2018vital signs\u2019 to improve care forpeople with chronic rheumatic diseases","volume":"67","author":"Pincus","year":"2009","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"R51-20230829","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10067-014-2827-4","article-title":"Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis","volume":"34","author":"Danve","year":"2015","journal-title":"Clin Rheumatol"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00296-015-3256-7","article-title":"A patient-reported outcome measures-based composite index (RAPID3) for the assessment of disease activity in ankylosing spondylitis","volume":"35","author":"Cinar","year":"2015","journal-title":"Rheumatol Int"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00002281-201903000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T06:52:24Z","timestamp":1693291944000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201903000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000588","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}